Skip to content

Clinical trials

Phase 2 Myositis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myositis Phase: Phase 2 Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20061
20081
20101
20131
20151
20181
20191
20203
20211
20222
20233
20244
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting5
Unknown status5
Active, not recruiting3
Terminated3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University People's Hospital4
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)3
Novartis Pharmaceuticals3
Kezar Life Sciences, Inc.2
Amgen1
Artiva Biotherapeutics, Inc.1
Assistance Publique - Hôpitaux de Paris1
Cartesian Therapeutics1
EMD Serono Research & Development Institute, Inc.1
Immunoforge Co. Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myositis27
Dermatomyositis11
Polymyositis9
Myositis, Inclusion Body3
Behcet Syndrome2
Immunoglobulin G4-Related Disease2
Lung Diseases, Interstitial2
Muscular Diseases2
Musculoskeletal Diseases2
Scleroderma, Systemic2

Trials

Showing 51 to 27 of 27. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.